Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy.
AffiliationCancer Research Institute, Slovak Academy of Sciences, Bratislava.
MetadataShow full item record
AbstractResistance of tumor cells to alkylating anticancer agents that produce adducts at the O6 position of guanine in DNA, the O6-alkylating agents, correlates with the expression of O6-alkylguanine-DNA alkyltransferase (ATase). O6-benzylguanine and related pseudosubstrates are able to inactivate human ATase in vitro and in vivo and they are being tested as chemotherapeutic adjuvants for enhancing the effectiveness of O6-alkylating drugs. On the other hand, the clinical consequences of ATase depletion may be fatal for some sensitive systems e.g. hematopoiesis. To overcome this problem, strategies for the protection of primary bone marrow cells by targeted transfer of pseudosubstrate-resistant ATase genes have been considered and recently achieved at the laboratory level. This approach could therefore be now extended to a clinical cancer gene therapy program.
CitationIncreasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy. 1998, 45 (4):181-6 Neoplasma
- O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells.
- Authors: Westerhof GR, Down JD, Blokland I, Wood M, Boudewijn A, Watson AJ, McGown AT, Ploemacher RE, Margison GP
- Issue date: 2001 May
- Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase.
- Authors: Hickson I, Fairbairn LJ, Chinnasamy N, Dexter TM, Margison GP, Rafferty JA
- Issue date: 1996 Oct
- Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.
- Authors: Rabik CA, Njoku MC, Dolan ME
- Issue date: 2006 Jun
- Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
- Authors: Gerson SL, Phillips W, Kastan M, Dumenco LL, Donovan C
- Issue date: 1996 Sep 1
- S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.
- Authors: Juillerat A, Juillerat-Jeanneret L
- Issue date: 2007 Mar